Author

K. Ven

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Approach:biophysical modeling· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

H. J. Thibaut· 2 shared J. Lammertyn· 2 shared J. Neyts· 2 shared K. Vanhoorelbeke· 2 shared L. Ampofo· 2 shared M. Imbrechts· 2 shared N. Callewaert· 2 shared N. Geukens· 2 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

H. J. Thibaut

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Specialized actin nanoscale layers control focal adhesion turnover

R. Kumari, K. Ven, M. Chastney, J. Peranen, J. Arron, L. Almeida-Souza, E. Kremneva, R. Poincloux, T. L. Chew, P. W. Gunning, J. Ivaska, P. Lappalainen

The paper identifies two new nanoscale actin layers in focal adhesions, showing their distinct roles in adhesion maturation and disassembly through Tpm1.6 and Tpm3.2.

bioRxiv · Feb 15, 2023 · PreprintCell Biology

Anti-SARS-CoV-2 human antibodies retaining neutralizing activity against SARS-CoV-2 B.1.1.529 (omicron)

M. Imbrechts, W. Kerstens, M. Rasulova, T. Vercruysse, W. Maes, L. Ampofo, K. Ven, J. Lammertyn, K. Vanhoorelbeke, N. Callewaert, J. Neyts, K. Dallmeier, P. Declerck, H. J. Thibaut, N. Geukens

The paper evaluates a panel of anti-SARS-CoV-2 monoclonal antibodies for neutralizing activity against SARS-CoV-2 delta and omicron variants, finding three mAbs retain activity, with mAb 3B8 showing potent neutralization against both.

bioRxiv · Dec 21, 2021 · PreprintImmunology

Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model

M. Imbrechts, W. Maes, L. Ampofo, N. Van den Berghe, B. Calcoen, D. Van Looveren, S. Noppen, K. Hollevoet, T. Vercruysse, X. Zhang, R. Abdelnabi, C. S.-Y. Foo, H. J. Thibaut, D. Jochmans, K. Ven, , N. Geukens

The paper identifies potent anti-SARS-CoV-2 mAbs that cure infection in hamsters and demonstrates gene-based delivery for in vivo protection against variants.

bioRxiv · Nov 25, 2021Immunology

Seipin traps triacylglycerols to facilitate their nanoscale clustering in the ER membrane

X. Prasanna, V. T. Salo, S. Li, K. Ven, H. Vihinen, E. Jokitalo, I. Vattulainen, E. Ikonen

This study shows seipin traps triacylglycerols in the ER membrane via its luminal hydrophobic helices, facilitating their nanoscale clustering and promoting TAG transfer to lipid droplets.

bioRxiv · Oct 26, 2020Cell Biology